40
Participants
Start Date
October 1, 2025
Primary Completion Date
October 1, 2026
Study Completion Date
October 1, 2027
Psilocybin
The intervention consists of two oral doses of 25 mg synthetic psilocybin administered in a controlled clinical setting, combined with psychological support. The psychological support includes preparatory sessions prior to psilocybin administration, support during the drug experience and integration sessions following each dosing session.
Psykiatrikliniken, Baravägen 1, Lund
Sten Theanders fond
UNKNOWN
Lions Forskningsfond Skåne
UNKNOWN
NorrskenMind
UNKNOWN
Region Skane
OTHER